Validation of the Dutch version of the Edmonton Symptom Assessment System

Autor: Sigrid C Vervoort, Karijn P M Suijkerbuijk, Everlien de Graaf, S. C. C. M. Teunissen, Michael Echteld, J. J. Koldenhof, Ellen J M de Nijs, Jan B Vos, Danielle Zweers, Frederieke H van der Baan, Petronella O. Witteveen, Ginette M Hesselmann, Alexander de Graeff
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Cancer Research
medicine.medical_specialty
Wilcoxon signed-rank test
Prom
lcsh:RC254-282
03 medical and health sciences
0302 clinical medicine
Quality of life
Predictive Value of Tests
Neoplasms
Positive predicative value
Criterion validity
medicine
Content validity
Humans
cancer
Radiology
Nuclear Medicine and imaging

Longitudinal Studies
health care economics and organizations
Original Research
Language
Netherlands
symptom assessment
Chi-Square Distribution
Receiver operating characteristic
business.industry
Clinical Cancer Research
Construct validity
Middle Aged
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Checklist
030104 developmental biology
ROC Curve
quality of life
Oncology
patient reported outcome measures
030220 oncology & carcinogenesis
Physical therapy
Female
business
Zdroj: Cancer Medicine, 2020 (9), 6111-6121
Cancer Medicine, Vol 9, Iss 17, Pp 6111-6121 (2020)
Cancer Medicine
ISSN: 2045-7634
Popis: Background The Utrecht Symptom Diary (USD) is a Dutch and adapted version of the Edmonton Symptom Assessment System, a patient‐reported outcome measurement (PROM) tool to asses and monitor symptoms in cancer patients. This study analyses the validity and responsiveness of the USD and the cutoff points to determine the clinical significance of a symptom score. Methods Observational longitudinal cohort study including adult in‐ and outpatients treated in an academic hospital in the Netherlands who completed at least one USD as part of routine care (2012‐2019). The distress thermometer and problem checklist (DT&PC) was used as a reference PROM. Content, construct and criterion validity, responsiveness, and cutoff points are shown with prevalences, area under receiver operating characteristic (ROC) curve, Chi‐squared test, Wilcoxon signed‐rank test, and positive and negative predictive values, respectively. Results A total of 3913 patients completed 22 400 USDs. Content validity was confirmed for all added USD items with prevalences of ≥22%. All USD items also present on the DT&PC demonstrated a good criterion validity (ROC >0.8). Construct validity was confirmed for the USD as a whole and for the items dry mouth, dysphagia and well‐being (P
The USD is a valid 12‐item PROM for the most prevalent symptoms in cancer patients, which has content, criterion, and construct validity and detects clinically important changes over time, in both curative and palliative phase.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje